Folgen
Guy Chouinard
Guy Chouinard
professor of psychiatry and medicine,Researcher Emeritus, Research Center University Mental Health
Bestätigte E-Mail-Adresse bei umontreal.ca
Titel
Zitiert von
Zitiert von
Jahr
Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT)
HY Meltzer, L Alphs, AI Green, AC Altamura, R Anand, A Bertoldi, ...
Archives of general psychiatry 60 (1), 82-91, 2003
16372003
A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
G Chouinard, B Jones, G Remington, D Bloom, D Addington, ...
Journal of clinical psychopharmacology 13 (1), 25-40, 1993
12251993
The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials
SR Marder, JM Davis, G Chouinard
J Clin Psychiatry 58 (12), 538-546, 1997
9001997
Extrapyramidal rating scale
G Chouinard
Can. J. Neurol. Sci. 7, 233, 1980
8801980
Manual for the extrapyramidal symptom rating scale (ESRS)
G Chouinard, HC Margolese
Schizophrenia research 76 (2-3), 247-265, 2005
4262005
Placebo-controlled study of gabapentin treatment of panic disorder
AC Pande, MH Pollack, J Crockatt, M Greiner, G Chouinard, RB Lydiard, ...
Journal of clinical psychopharmacology 20 (4), 467-471, 2000
4182000
Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics
G Chouinard, BD Jones
Am J Psychiatry 137 (1), 16-21, 1980
4111980
Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics
G Chouinard, BD Jones
Am J Psychiatry 137 (1), 16-21, 1980
4111980
Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound
G Chouinard
Journal of Clinical Psychiatry 65, 7-12, 2004
4032004
Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder
J Greist, G Chouinard, E DuBoff, A Halaris, SW Kim, L Koran, M Liebowitz, ...
Archives of General Psychiatry 52 (4), 289-295, 1995
4011995
Antidepressant efficacy of sertraline: a double-blind, placebo-and amitriptyline-controlled, multicenter comparison study in outpatients with major depression.
FW Reimherr, G Chouinard, CK Cohn, JO Cole, TM Itil, YD LaPierre, ...
The Journal of clinical psychiatry 51, 18-27, 1990
3441990
Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients
AM Ghadirian, G Chouinard, L Annable
The Journal of nervous and mental disease 170 (8), 463-467, 1982
3371982
Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study
G Chouinard, L Annable, R Fontaine, L Solyom
Psychopharmacology 77, 229-233, 1982
3331982
Neuroleptic-induced supersensitivity psychosis.
G Chouinard, BD Jones, L Annable
The American journal of psychiatry, 1978
2681978
Antimanic effect of clonazepam.
G Chouinard, SN Young, L Annable
Biological psychiatry 18 (4), 451-466, 1983
2651983
Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial
Y Dion, L Annable, P Sandor, G Chouinard
Journal of clinical psychopharmacology 22 (1), 31-39, 2002
2612002
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
WW Busse, ER Bleecker, JM FitzGerald, GT Ferguson, P Barker, ...
The lancet respiratory medicine 7 (1), 46-59, 2019
2502019
Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment
R Fontaine, G Chouinard, L Annable
Am J Psychiatry 141 (7), 848-852, 1984
2331984
Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.
G Chouinard, W Goodman, J Greist, M Jenike, S Rasmussen, K White, ...
Psychopharmacology bulletin 26 (3), 279-284, 1990
2311990
A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder
JH Greist, JW Jefferson, KA Kobak, G Chouinard, E DuBoff, A Halaris, ...
International clinical psychopharmacology 10 (2), 57-66, 1995
2151995
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20